During 2020, the company faced rapid technological development, particularly with respect to computing, automation, artificial intelligence, mobile connectivity, communications, and digitization, which affected its operations. The company is making significant investments, both organically and through acquisitions, to address the rapid pace of technological change in its served markets and to globalize its manufacturing, research and development, and customer-facing resources. The acquisition of cytiva has provided additional sales and earnings growth opportunities by expanding the business' geographic and product line diversity, including new product and service offerings that complement the company's current biologics workflow solutions. The company operates in a highly competitive environment, and its long-term growth and profitability depend on its ability to expand in high-growth geographies and segments, develop innovative and differentiated products and services, and improve operational efficiency and quality. The company's businesses monitor key competitors and customers to gauge relative performance and outlook, which is crucial for strategic decision-making. The company expects core sales growth driven by demand for instruments and consumables related to COVID-19 testing capabilities and supporting customers in the pursuit of new treatments and vaccines. The company has activated business continuity plans in response to the pandemic, including modifications to business practices and the development of return-to-work protocols. The company has also deployed its capabilities and expertise to address critical health needs related to COVID-19, including the development of diagnostic tests. The company continues to assess and update its plans to mitigate adverse impacts on its business, including supply chain management and operational flexibility. The integration of acquired businesses, such as cytiva, is expected to enhance the company's operational capabilities and market responsiveness. The company has recognized the importance of mobilizing and deploying IT-based resources in combination with leveraging the value of other resources and capabilities to transform into a competitive force. The company's IT capabilities have evolved to encompass the coordination of assets and internal processes, as well as interfirm transactions and relationships, which are essential for supporting business strategies and enhancing work processes. The company's focus on information management capability emphasizes the provision of data and information to users with appropriate levels of accuracy, timeliness, reliability, security, confidentiality, connectivity, and access, tailored to changing business needs. The ability to effectively support business needs through IT capabilities has become a key factor in transforming the firm and enhancing its competitive advantage. The company's strategic resource allocation and investment decisions are influenced by the need to adapt to market dynamics and external influences, ensuring that it remains agile and responsive to consumer demands and operational challenges.